Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc.

NYSE:CRL

Overview | Financials
Company Name Charles River Laboratories International, Inc.
Symbol CRL
Currency USD
Price 187.96
Market Cap 9,704,506,372
Dividend Yield 0%
52-week-range 161.65 - 275
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. James C. Foster J.D.
Website https://www.criver.com

An error occurred while fetching data.

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The

Related Stocks

Elanco Animal Health Incorporated logo

Elanco Animal Health Incorporated

ELAN

15.09 USD

Qiagen N.V. logo

Qiagen N.V.

QGEN

44.48 USD

Biohaven Pharmaceutical Holding Company Ltd. logo

Biohaven Pharmaceutical Holding Company Ltd.

BHVN

36.9 USD

Organon & Co. logo

Organon & Co.

OGN

20.49 USD

Universal Health Services, Inc. logo

Universal Health Services, Inc.

UHS

229.15 USD

Teleflex Incorporated logo

Teleflex Incorporated

TFX

244.53 USD

DaVita Inc. logo

DaVita Inc.

DVA

149.98 USD

Financials

Numbers are in millions USD

Numbers are in millions USD